Hosted on MSN7mon
GSK Announces FDA Acceptance of New Meningococcal Jab BLA
The MenABCWY vaccine candidate combines the antigenic components of GSK’s two popular licensed meningococcal vaccines, Bexsero (MenB) and Menveo (MenACWY). The MenABCWY combination targets the ...
pharmaphorum3d
GSK trails after Pfizer in 5-in-1 meningococcal vaccine race
The new vaccine is a combination of GSK’s already-approved vaccines Bexsero and Menveo and is designed to protect against meningitis and blood poisoning caused by the A, B, C, W, and Y ...
pharmaphorum9y
Deal agreed at last on GSK's Bexsero in UK
After months of delay, GlaxoSmithKline has agreed a deal with the UK government that will allow its meningitis B (MenB) vaccine Bexsero to be added to the NHS' routine childhood immunisation schedule.
Zacks.com on MSN15d
GSK Q3 Earnings Top, Stock Down on Lowered '24 View for Vaccine Sales
sales of Bexsero and Menveo rose 30% and 7%, respectively. Sales of the influenza vaccine, Fluarix, were down 22%. Sales of ...
MedPage Today22d
ACIP Votes to 'Harmonize' Dosing and Interval for Meningococcal B Vaccines
The new recommendations align the dosing and intervals for GSK's vaccine both with recent label changes and to that of Pfizer's meningococcal group B vaccine, MenB-FHbp (Trumenba). Aligning the ...